BluSense Diagnostics Overview

  • Founded
  • 2012
  • Status
  • Private
  • Employees
  • 50
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 10

BluSense Diagnostics General Information


Developer of a next-generation Point-Of-Care diagnostics platform designed to diagnose infectious diseases. The company's platform is developing a consumer-oriented point-of-care blood testing device based on a nanotechnology biosensing method that can deliver results in a few minutes with a single drop of blood, enabling people to monitor, control and manage virus outbreaks better.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Decision/Risk Analysis
Laboratory Services (Healthcare)
Primary Office
  • Fruebjergvej 3
  • 2100 Copenhagen
  • Denmark
+45 39 00 00 00

BluSense Diagnostics Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BluSense Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Accelerator/Incubator Completed Generating Revenue
8. Later Stage VC (Series B) 26-Apr-2018 Completed Generating Revenue
7. Grant 19-Dec-2017 00000 Completed Generating Revenue
6. Grant 14-Jun-2017 Completed Generating Revenue
5. Grant 01-Jan-2016 Completed Generating Revenue
4. Early Stage VC (Series A) 01-Jan-2015 Completed Generating Revenue
3. Grant 01-Jan-2015 Completed Generating Revenue
2. Grant 01-Jan-2014 Completed Generating Revenue
1. Grant 01-Jan-2013 Completed Generating Revenue
To view BluSense Diagnostics’s complete valuation and funding history, request access »

BluSense Diagnostics Executive Team (4)

Name Title Board Seat Contact Info
Filippo Bosco Ph.D Co-Founder, Board Member & Chief Executive Officer
Robert Burger Ph.D Co-Founder & Chief Operating Officer
Marco Donolato Ph.D Co-Founder, President and Chief Scientific Officer
Leif Helth Jensen Chairman
To view BluSense Diagnostics’s complete executive team members history, request access »

BluSense Diagnostics Board Members (3)

Name Representing Role Since
Chen Shang-Hao BluSense Diagnostics Board Member 000 0000
Leif Helth Jensen BluSense Diagnostics Chairman 000 0000
Shi-Chi Ho BluSense Diagnostics Board Member 000 0000
To view BluSense Diagnostics’s complete board members history, request access »

BluSense Diagnostics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BluSense Diagnostics Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Global Entrepreneurship Movement Government 000 0000 000000 0
U.S. Agency for International Development Government 000 0000 000000 0
Markedsmodningsfonden Venture Capital Minority 000 0000 000000 0
Eurostars Government 000 0000 000000 0
GoBeyond Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »